Tasas de recaída tras un tratamiento en Comunidades Terapéuticas: Una revisión sistemática

Autores/as

  • Daniel Suárez-Castro Smoking Cessation and Addictive Disorders Unit, Department of Clinical Psychology and Psychobiology, Faculty of Psychology, University of Santiago de Compostela, 15782, Santiago de Compostela, A Coruña, Spain
  • Diana Moreira Centro de Solidariedade de Braga/Projecto Homem, Universidade Catolica Portuguesa, Faculty of Philosophy and Social Sciences, Institute of Psychology and Neuropsychology of Porto – IPNP Health, Faculty of Psychology and Educational Sciences, University of Porto, Rua Alfredo Allen, 4200-135, Porto, Portugal
  • Andreia Azeredo Laboratory of Neuropsychophysiology, Faculty of Psychology and Educational Sciences, University of Porto, Rua Alfredo Allen, 4200-135, Porto, Portugal
  • Paulo C. Dias Universidade Católica Portuguesa, Faculty of Philosophy and Social Sciences, Centre for Philosophical and Humanistic Studies, Braga

DOI:

https://doi.org/10.20882/adicciones.1898

Palabras clave:

Comunidades terapéuticas, tasas de recaída, tratamiento por consumo de sustancias, trastornos relacionados con sustancias, programas en comunidades terapéuticas.

Resumen

Las Comunidades Terapéuticas (CT) son entornos residenciales que brindan rehabilitación psicosocial a las personas que consumen sustancias. En general, estas han demostrado su eficacia, aunque gran parte de la evidencia proviene de estudios con limitaciones metodológicas. Por tanto, el objetivo de la presente revisión sistemática fue evaluar los resultados de las CT en relación con las tasas de recaída. La búsqueda se realizó en EBSCO, PubMed y Web of Science con fecha límite del 29 de julio de 2021 y se basó en la declaración Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). De los 94 estudios encontrados, ocho cumplieron los criterios de selección, con un total de 2064 participantes de 40 CT. De los ocho estudios, siete eran estudios de cohortes y uno era un ensayo controlado aleatorizado. Los resultados revelan que las CT eran efectivas para reducir el consumo de sustancias, aunque persiste cierta incertidumbre con respecto a la persistencia a largo plazo. Se necesita más investigación que evalúe las tasas de recaída tras finalizar el tratamiento en las CT.

Citas

Alterman, A., McKay, J., Mulvaney, F., Cnaan, A., Cacciola, J., Tourian, K., Rutherford, M. & Merikle, E. (2000). Baseline prediction of 7-month cocaine abstinence for cocaine dependence patients. Drug and Alcohol Dependence, 59, 215–221. http://dx.doi.org/10.1016/S0376-8716(99)00124-6

Armijo-Olivo, S., Stiles, C. R., Hagen, N. A., Biondo, P. D. & Cummings, G. G. (2012). Assessment of study quality for systematic reviews: A comparison of the Cochrane Collaboration Risk of Bias Tool and the Effective Public Health Practice Project Quality Assessment Tool: Methodological research. Journal of Evaluation in Clinical Practice, 18, 12–18. https://doi.org/10.1111/j.1365-2753.2010.01516.x

Barreno, E. M., Domínguez-Salas, S., Díaz-Batanero, C., Lozano, Ó. M., Marín, J. A. L. & Verdejo-García, A. (2019). Specific aspects of cognitive impulsivity are longitudinally associated with lower treatment retention and greater relapse in therapeutic community treatment. Journal of Substance Abuse Treatment, 96, 33–38. http://dx.doi.org/10.1016/j.jsat.2018.10.004

Blodgett, J., Maisel, N., Fuh, I., Wilbourne, P. & Finney, J. (2014). How effective is continuing care for substance use disorders? A meta-analytic review. Journal of Substance Abuse Treatment, 46, 87–97. http://dx.doi.org/10.1016/j.jsat.2013.08.022

Bradizza, C., Stasiewicz, P. & Paas, N. (2006). Relapse to alcohol and drug use among individuals diagnosed with co-occurring mental health and substance use disorders: A review. Clinical Psychology Review, 26, 162–178. http://dx.doi.org/10.1016/j.cpr.2005.11.005

Broekaert, E., Raes, V., Kaplan, C. & Coletti, M. (1999). The design and effectiveness of therapeutic community research in Europe: An overview. European Addiction Research, 5, 21–35. http://dx.doi.org/10.1159/000018960

Dawson, D., Goldstein, R. & Grant, B. (2007). Rates and correlates of relapse among individuals in remission from DSM-IV alcohol dependence: A 3-year follow-up. Alcoholism: Clinical and Experimental Research, 31, 2036–2045. http://dx.doi.org/10.1111/j.1530-0277.2007.00536.x

de Andrade, D., Elphinston, R. A., Quinn, C., Allan, J. & Hides, L. (2019). The effectiveness of residential treatment services for individuals with substance use disorders: A systematic review. Drug and Alcohol Dependence, 201, 227–235. https://doi.org/10.1016/j.drugalcdep.2019.03.031

De Leon, G. (2000). The Therapeutic Community. Springer Publishing Company. https://doi.org/10.1891/9780826116673

De Leon, G. & Unterrainer, H. F. (2020). The Therapeutic Community: A unique social psychological approach to the treatment of addictions and related disorders. Frontiers in Psychiatry, 11, 786. https://doi.org/10.3389/fpsyt.2020.00786

Fernández-Hermida, J.-R., Secades-Villa, R., Fernández-Ludeña, J.-J. & Marina-González, P.A. (2002). Effectiveness of a Therapeutic Community treatment in Spain: A long-term follow-up study. European Addiction Research, 8, 22–29. http://dx.doi.org/10.1159/000049484

Fernández-Montalvo, J., López-Goñi, J. J., Illescas, C., Landa, N. & Lorea, I. (2008). Evaluation of a Therapeutic Community treatment program: A long-term follow-up study in Spain. Substance Use & Misuse, 43, 1362–1377. http://dx.doi.org/10.1080/10826080801922231

Gerwe, C. (2000). Chronic addiction relapse treatment: A study of the effectiveness of the high-risk identification and prediction treatment model. Journal of Substance Abuse Treatment, 19, 415–427. http://dx.doi.org/10.1016/S0740-5472(00)00136-7

Gossop, M., Marsden, J., Stewart, D. & Rolfe, A. (1999). Treatment retention and one-year outcomes for residential programs in England. Drug and Alcohol Dependence, 57, 89–98.

Gossop, M., Stewart, D., Browne, N. & Marsden, J. (2002). Factors associated with abstinence, lapse or relapse to heroin use after residential treatment: Protective effect of coping responses. Addiction, 97, 1259–1267. http://dx.doi.org/10.1046/j.1360-0443.2002.00227.x

Griffiths, M. (2005). A ‘components’ model of addiction within a biopsychosocial framework. Journal of Substance Use, 10, 191-197. https://doi.org/10.1080/14659890500114359

Griffith, J. & Ross, C. (2019). Treatment outcomes of substance abusing males: A 90-day residential treatment programme in Barbados. Caribbean Journal of Psychology, 11, 80–96.

Hendershot, C., Witkiewitz, K., George, W. & Marlatt, G. (2011). Relapse prevention for addictive behaviors. Substance Abuse Treatment, Prevention, and Policy, 6, 17. http://dx.doi.org/10.1186/1747-597x-6-17

Hubbard, R. L., Marsden, M. E., Rachal, J. V., Harwood, H. J., Cavenaugh, E. R. & Ginzburg, H. M. (1989). Drug abuse treatment: A national study of effectiveness. University of North Carolina Press.

Kelly, P., Deane, F., Baker, A., Byrne, G., Degan, T., Osborne, B., Townsend, C., McKay, J., Robinson, L., Oldmeadow, C., Lawson, K., Searles, A. & Lunn, J. (2020). Study protocol the Continuing Care Project: A randomised controlled trial of a continuing care telephone intervention following residential substance dependence treatment. BMC Public Health, 20. http://dx.doi.org/10.1186/s12889-020-8206-y

King, J., Dow, J. & Stevenson, B. (2016). Measuring outcomes for TC clients: Higher ground drug rehabilitation trust. Therapeutic Communities: The International Journal of Therapeutic Communities, 37, 121-130. https://doi.org/10.1108/tc-01-2016-0003

Lenaerts, E., Matheï, C., Matthys, F., Zeeuws, D., Pas, L., Anderson, P. & Aertgeerts, B. (2014). Continuing care for patients with alcohol use disorders: A systematic review. Drug and alcohol dependence, 135, 9–21. https://doi.org/10.1016/j.drugalcdep.2013.10.030

Malivert, M., Fatséas, M., Denis, C., Langlois, E. & Auriacombe, M. (2012). Effectiveness of therapeutic communities: A systematic review. European addiction research, 18, 1–11. https://doi.org/10.1159/000331007

McCusker, J., Vickers-Lahti, M., Stoddard, A., Hindin, R., Bigelow, C., Zorn, M., Garfield, F., Frost, R., Love, C. & Lewis, B. (1995). The effectiveness of alternative planned durations of residential drug abuse treatment. American Journal of Public Health, 85, 1426–1429. http://dx.doi.org/10.2105/ajph.85.10.1426

McKay, J. (2009). Continuing care research: What we have learned and where we are going. Journal of Substance Abuse Treatment, 36, 131–145. http://dx.doi.org/10.1016/j.jsat.2008.10.004

Mooney, S. R., Horton, P. A., Trakowski, J. H., Lenard, J. H., Barron, M. R., Nave, P. V., Gautreaux, M., S. & Lott, H. D. (2014). Military inpatient residential treatment of substance abuse disorders: The Eisenhower Army Medical Center experience. Military Medicine, 179, 674–678. http://dx.doi.org/10.7205/milmed-d-13-00308

Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J.M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., McGuinness, L. A.,… Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372, n71. https://doi.org/10.1136/bmj.n71

Pasareanu, A., Vederhus, J., Opsal, A., Kristensen, Ø. & Clausen, T. (2016). Improved drug-use patterns at 6 months post-discharge from inpatient substance use disorder treatment: Results from compulsorily and voluntarily admitted patients. BMC Health Services Research, 16, 291. http://dx.doi.org/10.1186/s12913-016-1548-6

Reif, S., George, P., Braude, L., Dougherty, R. H., Daniels, A. S., Ghose, S. S. & Delphin-Rittmon, M. E. (2014). Residential treatment for individuals with substance use disorders: Assessing the evidence. Psychiatric Services, 65, 301–312. https://doi.org/10.1176/appi.ps.201300242

Šefránek, M. & Miovský, M. (2017). Treatment outcome evaluation in Therapeutic Communities in the Czech Republic: Changes in methamphetamine use and related problems one year after discharge. Journal of Groups in Addiction & Recovery, 12, 68-85. https://doi.org/10.1080/1556035x.2017.1280718

Šefránek, M. & Miovský, M. (2017b). Treatment outcome evaluation in Therapeutic Communities in the Czech Republic: Alcohol consumption and other results one year after discharge. Alcoholism Treatment Quarterly, 36, 54-71. https://doi.org/10.1080/07347324.2017.1387036

Simpson, D. D. & Sells, S. B. (1982). Effectiveness of treatment for drug abuse: An overview of the DARP research program. Advances in Alcohol and Substance Abuse, 2, 7–29. http://dx.doi.org/10.1300/J251v02n01_02

Smith, L. A., Gates, S. & Foxcroft, D. (2006). Therapeutic communities for substance related disorder. The Cochrane database of systematic reviews, 1, CD005338. https://doi.org/10.1002/14651858.CD005338.pub2

Stevens, L., Goudriaan, A. E., Verdejo-García, A., Dom, G., Roeyers, H. & Vanderplasschen, W. (2015). Impulsive choice predicts short-term relapse in substance-dependent individuals attending an in-patient detoxification programme. Psychological Medicine, 45, 2083–2093. http://dx.doi.org/10.1017/S003329171500001X

Suter, M., Strik, W. & Moggi, F. (2011). Depressive symptoms as a predictor of alcohol relapse after residential treatment programs for alcohol use disorder. Journal of Substance Abuse Treatment, 41, 225–232. http://dx.doi.org/10.1016/j.jsat.2011.03.005

Tims, F. & Leukefeld, C. (Eds.). (1986). Relapse and recovery in drug abuse (NIDA Monograph 72). Department of Health and Human Services.

Vanderplasschen, W., Colpaert, K., Autrique, M., Rapp, R. C., Pearce, S., Broekaert, E. & Vandevelde, S. (2013). Therapeutic Communities for addictions: A review of their effectiveness from a recovery-oriented perspective. The Scientific World Journal, 2013, 1–22. https://doi.org/10.1155/2013/427817

Verdejo-Garcia, A., Alcazar-Corcoles, M. & Albein-Urios, N. (2018). Neuropsychological interventions for decision-making in addiction: A systematic review. Neuropsychology Review, 29, 79–92. https://doi.org/10.1007/s11065-018-9384-6

Volkow, N., Koob, G. F. & McLellan, T. (2016). Neurobiologic advances from the brain disease model of addiction. The New England Journal of Medicine, 374, 363–371. http://dx.doi.org/10.1056/NEJMra1511480

Witkiewitz, K. & Marlatt, G. (2007). Modeling the complexity of post-treatment drinking: It’s a rocky road to relapse. Clinical Psychology Review, 27, 724–738. http://dx.doi.org/10.1016/j.cpr.2007.01.002

Publicado

2023-11-29

Número

Sección

Originales